Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities.

Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities.

Item
http://www.wikidata.org/entity/Q37186178
Structural basis for bifunctional peptide recognition at human δ-opioid receptorMitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.Molecular Pharmacology of δ-Opioid Receptors.The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice.New developments in the pharmacotherapy of neuropathic chronic pelvic pain.Pharmacological Management of Chronic Pelvic Pain in Women.Asymmetric synthesis and in vitro and in vivo activity of tetrahydroquinolines featuring a diverse set of polar substitutions at the 6 position as mixed-efficacy μ opioid receptor/δ opioid receptor ligands.How Oliceridine (TRV-130) Binds and Stabilizes a μ-Opioid Receptor Conformational State That Selectively Triggers G Protein Signaling Pathways.Conformational Heterogeneity of Intracellular Loop 3 of the μ-opioid G-protein Coupled Receptor.Benzylideneoxymorphone: A new lead for development of bifunctional mu/delta opioid receptor ligands.In Vivo Effects of μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Peptidomimetics Following Acute and Repeated Administration.Computer-Aided Drug Design Methods.
P2860

Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities.

Item
http://www.wikidata.org/entity/Q37186178
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synthesis, modeling, and pharm ...... reduced tolerance liabilities.
@en
Synthesis, modeling, and pharm ...... reduced tolerance liabilities.
@nl
type
label
Synthesis, modeling, and pharm ...... reduced tolerance liabilities.
@en
Synthesis, modeling, and pharm ...... reduced tolerance liabilities.
@nl
prefLabel
Synthesis, modeling, and pharm ...... reduced tolerance liabilities.
@en
Synthesis, modeling, and pharm ...... reduced tolerance liabilities.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Synthesis, modeling, and pharm ...... reduced tolerance liabilities
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932